Healthcare provider profile · identity verified

Amy Spears Hix, M.D.

Family Practice · CROSSVILLE, TN · NPI 1932100328

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	328	102
Levothyroxine Sodium	Levothyroxine Sodium	291	84
Lisinopril	Lisinopril	220	70
Amlodipine Besylate	Amlodipine Besylate	207	66
Omeprazole	Omeprazole	156	52
Losartan Potassium	Losartan Potassium	154	45
Metoprolol Succinate	Metoprolol Succinate	143	41
Gabapentin	Gabapentin	137	39
Furosemide	Furosemide	123	48
Prednisone	Prednisone	122	88
Rosuvastatin Calcium	Rosuvastatin Calcium	114	32
Alprazolam	Alprazolam	105	17
Meloxicam	Meloxicam	101	33
Metformin Hcl Er	Metformin Hcl	95	29
Potassium Chloride	Potassium Chloride	95	44
Trazodone Hcl	Trazodone Hcl	94	32
Metoprolol Tartrate	Metoprolol Tartrate	92	30
Hydrochlorothiazide	Hydrochlorothiazide	89	27
Pantoprazole Sodium	Pantoprazole Sodium	89	31
Citalopram Hbr	Citalopram Hydrobromide	84	24
Famotidine	Famotidine	84	27
Metformin Hcl	Metformin Hcl	82	26
Eliquis	Apixaban	80	26
Sertraline Hcl	Sertraline Hcl	72	25
Montelukast Sodium	Montelukast Sodium	70	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	14
Clonazepam	Clonazepam	69	suppressed
Allopurinol	Allopurinol	67	22
Tamsulosin Hcl	Tamsulosin Hcl	67	20
Clopidogrel	Clopidogrel Bisulfate	66	21
Ondansetron Odt	Ondansetron	64	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	27
Fluticasone Propionate	Fluticasone Propionate	59	21
Lorazepam	Lorazepam	58	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	12
Simvastatin	Simvastatin	55	15
Pregabalin	Pregabalin	47	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	20
Farxiga	Dapagliflozin Propanediol	41	11
Alendronate Sodium	Alendronate Sodium	39	15
Pioglitazone Hcl	Pioglitazone Hcl	39	11
Benazepril Hcl	Benazepril Hcl	38	12
Mirtazapine	Mirtazapine	38	12
Fluoxetine Hcl	Fluoxetine Hcl	36	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Lovastatin	Lovastatin	32	suppressed
Spironolactone	Spironolactone	32	14
Trulicity	Dulaglutide	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Cefdinir	Cefdinir	31	28
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	28
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Glipizide	Glipizide	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Ozempic	Semaglutide	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Levofloxacin	Levofloxacin	27	24
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Azithromycin	Azithromycin	25	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Estradiol	Estradiol	25	11
Glimepiride	Glimepiride	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	13
Atenolol	Atenolol	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	22
Lactulose	Lactulose	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Indapamide	Indapamide	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Ramipril	Ramipril	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Methimazole	Methimazole	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Diazepam	Diazepam	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Cephalexin	Cephalexin	15	12
Clarithromycin	Clarithromycin	15	14
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Topiramate	Topiramate	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Glipizide Er	Glipizide	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Baclofen	Baclofen	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Finasteride	Finasteride	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error